News: API Australian Pharmaceutical Industries Posts FY Underlying NPAT Of A$39.3 Mln

Oct 28 (Reuters) - Australian Pharmaceutical Industries Ltd (API) :

• FY REVENUE A$4 BLN VS A$4.02 BLN
• FY UNDERLYING NPAT A$39.3 MLN VS A$31.5 MLN
• DECLARES FULLY FRANKED FINAL DIVIDEND OF 2 AU CENTS PER SHARE
• SEES CONSUMER BRANDS EXIT OF MANUFACTURING TO RESULT IN A$5 MILLION INCREMENTAL EBIT FROM MID FY23
• SEES RECALIBRATION OF PRICELINE CO STORES OVER PAST 2 YEARS WILL IMPROVE PROFITABILITY BY A$3.4 MILLION FROM FY22
• SEES NEW AUTOMATED DC WILL DELIVER A$8 MILLION EBIT FROM START OF FY23